ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 132 filers reported holding ALLAKOS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $223,421 | -12.1% | 50,207 | +66.2% | 0.00% | 0.0% |
| Q4 2022 | $254,284 | -92.3% | 30,200 | -97.1% | 0.00% | -90.9% |
| Q2 2022 | $3,294,000 | -47.0% | 1,052,332 | -3.4% | 0.01% | -38.9% |
| Q1 2022 | $6,212,000 | -30.9% | 1,089,868 | +18.7% | 0.02% | -5.3% |
| Q4 2021 | $8,992,000 | +122.4% | 918,533 | +2305.5% | 0.02% | +111.1% |
| Q3 2021 | $4,043,000 | -78.3% | 38,185 | -82.5% | 0.01% | -78.6% |
| Q2 2021 | $18,647,000 | +17.5% | 218,421 | +58.0% | 0.04% | +2.4% |
| Q1 2021 | $15,864,000 | +1426.9% | 138,216 | +1763.0% | 0.04% | +1266.7% |
| Q4 2020 | $1,039,000 | -33.4% | 7,419 | -61.3% | 0.00% | -50.0% |
| Q3 2020 | $1,561,000 | +6.4% | 19,169 | -41.9% | 0.01% | -50.0% |
| Q1 2020 | $1,467,000 | – | 32,984 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |